Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin
Lubawy, W.C.; Kostenbauder, H.B.; Stavchansky, S.A.
Research Communications in Chemical Pathology and Pharmacology 8(1): 75-82
1974
ISSN/ISBN: 0034-5164 PMID: 4847907 Document Number: 72547
Document emailed within 1 workday
Related Documents
Yamada, N.; Arai, Y.; Funayama, K.; Kadowaki, S.; Takahashi, K.; Umezu, K. 1995: Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities Arzneimittel-Forschung 45(1): 33-35Pence, D.H.; Schnell, R.C. 1980: Cadmium-induced inhibition of zoxazolamine metabolism in male and female rats Research Communications in Chemical Pathology and Pharmacology 27(2): 413-416
Reidy, G.F.; Mehta, I.; Murray, M. 1989: Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics Molecular Pharmacology 35(5): 736-743
Stavchansky, S.A.; Kostenbauder, H.B.; Lubawy, W.C. 1975: Kinetic and spectral studies of type i and type Ii compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin Drug Metabolism and Disposition: the Biological Fate of Chemicals 3(6): 557-564
Fuller, R.W.; Rathbun, R.C.; Parli, C.J. 1976: Inhibition of drug metabolism by fluoxetine Research Communications in Chemical Pathology and Pharmacology 13(2): 353-356
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588
Tarrús, E.; García, I.; Roberts, D.J.; Segura, J. 1987: An animal model for the detection of drug-induced inhibition of caffeine metabolism Methods and Findings in Experimental and Clinical Pharmacology 9(5): 311-316
Moore, B.P.; Cohen, G.M. 1978: Metabolism of benzo(a)pyrene and its major metabolites to ethyl acetate-soluble and water-soluble metabolites by cultured rodent trachea Cancer Research 38(9): 3066-3075
Freundt, K.J.; Kuttner, P.; Dreher, W. 1976: Specifity and sensitivity of the inhibition of drug metabolism following inhalation of carbon disulphide-air mixtures Arzneimittel-Forschung 26(5): 793-799
Pár, A.; Horváth, T.; Beró, T.; Kádas, I.; Pakodi, F.; Jávor, T. 1984: Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease Acta Physiologica Hungarica 64(3-4): 449-454
Corpet, D.E.; Bories, G.F. 1987: 3H]chloramphenicol metabolism in human volunteer: oxamic acid as a new major metabolite Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(6): 925-927
Evens, R.P.; Yanchick, V. 1984: Unit-dose systems: drug waste and drug processing time in a long-term care facility Hospital Formulary 19(6): 454-458
Kornchankul, W.; Hamed, E.; Parikh, N.H.; Sakr, A. 2002: Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer Die Pharmazie 57(1): 49-53
Cossum, P.A.; Roberts, M.S. 1985: Metabolite inhibition of nitroglycerin metabolism in sheep tissue homogenates Journal of Pharmacy and Pharmacology 37(11): 807-809
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Ahmed, S.Masud.; Naher, N.; Hossain, T.; Rawal, L.Bahadur. 2017: Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study Journal of Pharmaceutical Policy and Practice 10: 21
Watson, J.D.; Spellacy, W.N. 1971: Neonatal effects of maternal treatment with the anticonvulsant drug diphenylhydantoin Obstetrics and Gynecology 37(6): 881-885
Jaruratanasirikul, S.; Cooper, A.D.; Blaschke, T.F. 1992: Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(3): 379-382
Krivoy, N.; Zuckerman, T.; Elkin, H.; Froymovich, L.; Rowe, J.M.; Efrati, E. 2012: Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity Current Drug Safety 7(3): 211-217